Integra LifeSciences | IART - Current Assets


Integra LifeSciences reported $1.14B in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Abbott USD 26B 1.16B Dec/2025
AtriCure USD 322.52M 21.41M Dec/2025
Baxter International USD 6.87B 61M Dec/2025
Becton, Dickinson and Co. USD 9.19B 66M Dec/2025
Boston Scientific USD 8.79B 759M Dec/2025
CONMED USD 672.86M 10.7M Dec/2025
Cooper Companies USD 2.11B 31.4M Sep/2025
Dexcom USD 4.03B 1.19B Dec/2025
Edwards Lifesciences USD 6.36B 218.3M Sep/2025
Globus Medical USD 1.92B 194.46M Sep/2025
HeartBeam USD 2.13M 3.24M Sep/2025
Hologic USD 3.84B 175.3M Dec/2025
Insulet USD 1.91B 54.6M Dec/2025
Integra LifeSciences USD 1.14B 754K Sep/2025
Intuitive Surgical USD 12.4B 927.3M Dec/2025
J&J USD 55.62B 1.01B Dec/2025
Medtronic USD 24B 773M Sep/2025
Merit Medical Systems USD 985.53M 62.46M Sep/2025
Orthofix International USD 394.17M 1.66M Sep/2025
Smith & Nephew USD 4.63B 169M Dec/2025
Stryker USD 14.76B 1.04B Dec/2025
Tandem Diabetes Care USD 618.14M 1.2M Dec/2025
Teleflex USD 1.99B 262.12M Sep/2025
Zimmer Biomet Holdings USD 5.12B 715M Dec/2025